Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2024 · 48 positions · Total reported value $1.82B · Top-10 concentration 65.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Cormorant Asset Management, LP disclosed 48 equity positions with a combined reported value of $1.82B. The filing implies a focused portfolio: its ten largest positions account for 65.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were MLTX ($459.96M), PRAX ($130.31M), JANX ($112.43M). By sector, the heaviest allocations are Health Care 79.4%, Industrials 3.4%. Versus the prior quarter, allocation shifted toward Health Care (+7.1pp) and away from Other (-7.0pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q4 2024 were DRUG ($38.16M), OKUR ($15.80M), SEPN ($12.82M).

Of the 2 positions fully exited versus the prior quarter, the largest were LBPH ($93.01M), ANAB ($11.47M), KRRO ($8.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • DRUG BRIGHT MINDS BIOSCIENCES INC · $38.16M
  • OKUR ONKURE THERAPEUTICS INC · $15.80M
  • SEPN SEPTERNA INC · $12.82M
  • IBRX IMMUNITYBIO INC · $7.68M
  • ELVN ENLIVEN THERAPEUTICS INC · $5.62M
  • SPRY ARS PHARMACEUTICALS INC · $5.28M
  • KALA KALA BIO INC · $4.19M
  • OMER OMEROS CORP · $2.96M

Fully Exited (vs previous quarter)

  • LBPH LONGBOARD PHARMACEUTICALS IN · prev qtr: $93.01M
  • ANAB ANAPTYSBIO INC · prev qtr: $11.47M
  • KRRO KORRO BIO INC · prev qtr: $8.88M
  • SLN SILENCE THERAPEUTICS PLC · prev qtr: $7.27M
  • NGNE NEUROGENE INC · prev qtr: $4.50M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.4%
Other 17.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $459.96M 25.26%
25.26%
Hold
2 1.69M $130.31M 7.16%
7.16%
Add
3 2.10M $112.43M 6.17%
6.17%
Add
4 1.30M $99.70M 5.47%
5.47%
Add
5 3.41M $90.95M 5.00%
5.00%
Hold
6 3.25M $83.53M 4.59%
4.59%
Add
7 8.32M $62.02M 3.41%
3.41%
Hold
8 2.94M $52.17M 2.87%
2.87%
Hold
9 1.00M $51.13M 2.81%
2.81%
Reduce
10 650.00K $44.88M 2.46%
2.46%
Add
11 1.60M $43.90M 2.41%
2.41%
Reduce
12 2.56M $42.91M 2.36%
2.36%
Hold
13 1.06M $38.16M 2.10%
2.10%
New
14 425.00K $34.79M 1.91%
1.91%
Reduce
15 740.00K $31.12M 1.71%
1.71%
Hold
16 2.91M $30.54M 1.68%
1.68%
Hold
17 1.05M $30.53M 1.68%
1.68%
Hold
18 1.47M $28.11M 1.54%
1.54%
Hold
19 2.38M $28.02M 1.54%
Form 4 · 1 →
1.54%
Hold
20 500.00K $27.68M 1.52%
1.52%
Hold
21 325.00K $27.50M 1.51%
1.51%
Reduce
22 1.82M $25.42M 1.40%
1.40%
Reduce
23 400.00K $22.39M 1.23%
1.23%
Hold
24 775.00K $22.23M 1.22%
1.22%
Reduce
25 1.18M $17.05M 0.94%
0.94%
Hold
26 2.15M $16.88M 0.93%
0.93%
Hold
27 1.84M $15.80M 0.87%
0.87%
New
28 585.46K $15.60M 0.86%
0.86%
Hold
29 2.13M $15.59M 0.86%
0.86%
Hold
30 2.32M $15.45M 0.85%
0.85%
Add
31 2.63M $15.22M 0.84%
0.84%
Add
32 3.57M $13.85M 0.76%
0.76%
Hold
33 700.00K $12.90M 0.71%
0.71%
Hold
34 560.00K $12.82M 0.70%
0.70%
New
35 3.00M $7.68M 0.42%
0.42%
New
36 250.00K $5.62M 0.31%
0.31%
New
37 500.00K $5.28M 0.29%
0.29%
New
38 1.39M $4.67M 0.26%
0.26%
Hold
39 603.03K $4.19M 0.23%
0.23%
New
40 593.04K $4.15M 0.23%
0.23%
Hold
41 425.00K $3.33M 0.18%
0.18%
Reduce
42 300.00K $3.19M 0.17%
0.17%
Reduce
43 300.00K $2.96M 0.16%
0.16%
New
44 254.16K $2.80M 0.15%
0.15%
Reduce
45 55.54K $2.07M 0.11%
0.11%
Reduce
46 350.00K $1.97M 0.11%
0.11%
Hold
47 103.63K $1.04M 0.06%
0.06%
Hold
48 200.00K $316.00K 0.02%
0.02%
Reduce

FAQ

What did Cormorant Asset Management, LP buy in 2024-Q4?

In its 2024-Q4 13F filing, Cormorant Asset Management, LP reported 48 equity positions worth $1.82B in aggregate; its largest disclosed positions were MLTX ($459.96M), PRAX ($130.31M), JANX ($112.43M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $1.82B of long equity holdings across 48 positions as of 2024-Q4. Top-10 holdings account for 65.2% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →